keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cenupatide acetate is an urokinase plasminogen activator receptor (uPAR) inhibitor for treating disorders associated altered cell migration, such as cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 68.00 | |
2 mg | In stock | $ 97.00 | |
5 mg | In stock | $ 137.00 | |
10 mg | In stock | $ 227.00 | |
25 mg | In stock | $ 417.00 | |
50 mg | In stock | $ 619.00 | |
100 mg | In stock | $ 879.00 | |
500 mg | In stock | $ 1,790.00 |
Description | Cenupatide acetate is an urokinase plasminogen activator receptor (uPAR) inhibitor for treating disorders associated altered cell migration, such as cancer. |
In vivo | Cenupatide inhibits uPAR binding to the formyl peptide receptors (FPRs) can improve kidney lesions in a rat model of streptozotocin (STZ)-induced diabetes [1]. |
Synonyms | Cenupatide acetate(1006388-38-0 Free base) |
Molecular Weight | 677.8 |
Formula | C30H51N11O7 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 10 mg/mL (14.8 mM), Sonification is recommended
DMSO: 5 mg/mL (7.4 mM), Sonification is recommended
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cenupatide acetate Others Cenupatide Acetate Cenupatide acetate(1006388-38-0 Free base) inhibitor inhibit